Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardio Diagnostics Holdings Inc. - Common stock (NQ: CDIO )

0.2664 -0.0414 (-13.45%)
Streaming Delayed Price Updated: 2:57 PM EST, Nov 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardio Diagnostics Holdings Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 Next >
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
CDIO Stock Earnings: Cardio Diagnostics Hldgs Misses Revenue for Q4 2023
CDIO stock results show that Cardio Diagnostics Hldgs missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
BlackRock Acquires Stake In Cardio Diagnostics
--News Direct-- 
Via News Direct
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
BlackRock Bolsters Wealth Management Arsenal With SpiderRock Advisors Acquisition, Expanding SMA Solutions
BlackRock (NYSE: BLK) to acquire full ownership of SpiderRock Advisors, expanding offerings in customized option overlay strategies for U.S. wealth market. 
Via Benzinga
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters
--News Direct-- 
Via News Direct
Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters
A precision cardiovascular medicine company’s innovative AI-driven epigenetic-genetic blood tests will soon be available in one of the nation’s largest retailers. 
Via Benzinga
BlackRock Acquires Stake In Cardio Diagnostics
BlackRock (NYSE: BLK) has acquired a minor stake in Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company. In BlackRock’s 13G filing on Feb. 
Via Benzinga
Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Topics Death
Exposures Death
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
--News Direct-- 
Via News Direct
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
Cardio Diagnostics’ AI-driven coronary heart disease (CHD) tests have taken another promising step in their evolution. 
Via Benzinga
Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
--News Direct-- 
Via News Direct
Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
An artificial intelligence-powered precision cardiovascular medicine company named Cardio Diagnostics (NASDAQ: CDIO) has launched a first-of-its-kind platform called 
Via Benzinga
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Cardio Diagnostics Holdings Stock Is Racing Higher
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) shares are rocketing higher Tuesday after the company announced that the American Medical Association (AMA) has assigned a dedicated Current Procedural... 
Via Benzinga
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
Cardio Diagnostics’ Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association
--News Direct-- 
Via News Direct
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.